Be mindful when using imperfect evidence for public health decision making: Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway.
Source: BMJ Comments - Category: General Medicine Source Type: forums
More News: AstraZeneca | Bleeding | Denmark Health | General Medicine | International Medicine & Public Health | Norway Health | Thrombocytopenia | Thrombosis | Vaccines